NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK‐NRF2 signaling

Patients with hepatocellular carcinoma (HCC) are usually diagnosed at the later stages and have poor survival outcomes. New molecules are urgently needed for the prognostic predication and individual treatment. Our study showed that high levels of NQO1 expression frequently exist in HCC with an obvi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yun, Zheng, Jie, Wang, Mengchao, Zhang, Jin, Tian, Tao, Wang, Zhiheng, Yuan, Shengxian, Liu, Lei, Zhu, Peng, Gu, Fangming, Fu, Siyuan, Shan, Yunfeng, Pan, Zeya, Zhou, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894015/
https://www.ncbi.nlm.nih.gov/pubmed/33222332
http://dx.doi.org/10.1111/cas.14744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894015/
https://www.ncbi.nlm.nih.gov/pubmed/33222332
http://dx.doi.org/10.1111/cas.14744

Ejemplares similares